These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6172951)

  • 1. L-tryptophan-carbidopa trial in patients with long-standing progressive myoclonus epilepsy.
    Leino E; MacDonald E; Airaksinen MM; Riekkinen PJ; Salo H
    Acta Neurol Scand; 1981 Aug; 64(2):132-41. PubMed ID: 6172951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropharmacology of progressive myoclonus epilepsy: response to 5-hydroxy-L-tryptophan.
    Pranzatelli MR; Tate E; Huang Y; Haas RH; Bodensteiner J; Ashwal S; Franz D
    Epilepsia; 1995 Aug; 36(8):783-91. PubMed ID: 7543407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with progressive myoclonus epilepsy.
    Leino E; MacDonald E; Airaksinen MM; Riekkinen PJ
    Acta Neurol Scand; 1980 Jul; 62(1):41-54. PubMed ID: 6163302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease of GABA in the cerebrospinal fluid of patients with progressive myoclonus epilepsy and its correlation with the decrease of 5HIAA and HVA.
    Airaksinen EM; Leino E
    Acta Neurol Scand; 1982 Dec; 66(6):666-72. PubMed ID: 6187174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficient intestinal absorption of L-tryptophan in progressive myoclonus epilepsy without Lafora bodies.
    Koskiniemi ML
    J Neurol Sci; 1980 Jul; 47(1):1-6. PubMed ID: 6157783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam.
    Chadwick D; Hallett M; Harris R; Jenner P; Reynolds EH; Marsden CD
    Brain; 1977 Sep; 100(3):455-87. PubMed ID: 412560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open trial with levodopa-carbidopa combination to patients with long-standing progressive myoclonus epilepsy.
    Leino E
    Acta Neurol Scand; 1981 Jun; 63(6):389-94. PubMed ID: 6798816
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa.
    Van Woert MH; Rosenbaum D; Howieson J; Bowers MB
    N Engl J Med; 1977 Jan; 296(2):70-5. PubMed ID: 401457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient effect of L-tryptophan in progressive myoclonus epilepsy without Lafora bodies: clinical and electrophysiological study.
    Koskiniemi M; Hyyppä M; Sainio K; Salmi T; Sarna S; Uotila L
    Epilepsia; 1980 Aug; 21(4):351-7. PubMed ID: 6772434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin and myoclonus.
    Van Woert MH; Jutkowitz R; Rosenbaum D; Bowers MB
    Monogr Neural Sci; 1976; 3():71-80. PubMed ID: 790170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indole levels in human lumbar and ventricular cerebrospinal fluid and the effect of L-tryptophan administration.
    Koskiniemi M; Laakso J; Kuurne T; Laipio M; Härkönen M
    Acta Neurol Scand; 1985 Feb; 71(2):127-32. PubMed ID: 2580417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and clinical studies on epileptic patients during two phase I trials with the novel anticonvulsant taltrimide.
    Airaksinen EM; Koivisto K; Keränen T; Pitkänen A; Riekkinen PJ; Oja SS; Marnela KM; Partanen JV; Tokola O; Gothóni G
    Epilepsy Res; 1987 Sep; 1(5):308-11. PubMed ID: 3143554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486.
    Van Woert MH; Sethy VH
    Neurology; 1975 Feb; 25(2):135-40. PubMed ID: 1078720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, biochemical, and pharmacological observation in a patient with postasphyxic myoclonus: association to serotonin hyperactivity.
    Giménez-Roldán S; Mateo D; Muradas V; De Yebenes JG
    Clin Neuropharmacol; 1988 Apr; 11(2):151-60. PubMed ID: 2454156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of taurine, GABA, 5-HT, and dopamine by blood platelets in progressive myoclonus epilepsy.
    Airaksinen EM
    Epilepsia; 1979 Oct; 20(5):503-10. PubMed ID: 38959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indoleamine compartmentation in human blood.
    Demet EM; Halaris AE; Bhatarakamol S
    Clin Chim Acta; 1978 Oct; 89(2):285-92. PubMed ID: 709877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of myoclonus with L-5-hydroxytryptophan and carbidopa: clinical, electrophysiological, and biochemical observations.
    Thal LJ; Sharpless NS; Wolfson L; Katzman R
    Ann Neurol; 1980 Jun; 7(6):570-6. PubMed ID: 6969054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinolinic acid concentrations in brain and cerebrospinal fluid of patients with intractable complex partial seizures.
    Heyes MP; Wyler AR; Devinsky O; Yergey JA; Markey SP; Nadi NS
    Epilepsia; 1990; 31(2):172-7. PubMed ID: 1690639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers.
    Williams WA; Shoaf SE; Hommer D; Rawlings R; Linnoila M
    J Neurochem; 1999 Apr; 72(4):1641-7. PubMed ID: 10098872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel neurodevelopmental syndrome responsive to 5-hydroxytryptophan and carbidopa.
    Ramaekers VT; Senderek J; Häusler M; Häring M; Abeling N; Zerres K; Bergmann C; Heimann G; Blau N
    Mol Genet Metab; 2001 Jun; 73(2):179-87. PubMed ID: 11386854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.